L. Yin - Biostatistics and Research Decision Sciences, Merck & Co. Inc.

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 13 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

178P KEYNOTE-859 Update: Pembrolizumab + Chemotherapy for Advanced HER2-negative Gastric or Gastroesophageal Junction (G/GEJ) Cancer

M.H. Ryu,S.Y. Rha,L.S. Wyrwicz,P.E. Yanez Weber,Y. Bai,J. Lee,F. Rivera Herrero,G.V. Alves,M. Garrido,K-K. Shiu,M. González Fernández, J. Li, M.A. Lowery,T. Cil,F. Cruz, D-Y. Oh,L. Yin,S. Bordia,P. Bhagia,S. Qin

Annals of Oncology (2024): S1473-S1474

Cited0Views0Bibtex

M. Lowery,L. Wyrwicz, D-Y. Oh,K-K. Shiu,P. Yanez Weber,Y. Bai,J. Lee,F. Rivera,G. Alves,M. Garrido,M. González Fernández, J. Li,T. Cil,F. Cruz,S. Qin,L. Yin,A. Valderrama,S. Bordia,S.Y. Rha

Annals of Oncology (2023): S854-S855

Cited0Views0Bibtex

O-3 Additional Data from the KEYNOTE-859 Study of Pembrolizumab Plus Chemotherapy Versus Placebo Plus Chemotherapy for Advanced HER2-negative Gastric or Gastroesophageal Junction (G/GEJ) Cancer

L. Wyrwicz, D. Oh,P. Weber,Y. Bai,M. Ryu, J. Lee,F. Rivera,G. Vasconcelos Alves,M. Garrido,K. Shiu,M. Gonzalez Fernandez, J. Li,M. Lowery,T. Cil,F. Cruz,S. Qin,L. Yin,S. Bordia,P. Bhagia,S. Rha

ANNALS OF ONCOLOGY (2023): S181-S181

Cited1Views0Bibtex

138MO Pembrolizumab (pembro) or Placebo (pbo) Plus Chemotherapy (chemo) for Advanced HER2-negative Gastric/gastroesophageal Junction (G/GEJ) Adenocarcinoma (KEYNOTE-859): Asia Subgroup Analysis

D-Y. Oh,Y. Bai,M.H. Ryu, J. Lee, J. Li,S. Luo,H. Pan,Y. Qu,J. Lu,L. Yang,H. Yasui,H. Yabusaki,C.J. Yen,W.W.L. Chan, K. Yamaguchi,K-H. Yeh,L. Yin,S. Bordia,P. Bhagia,S.Y. Rha

Annals of Oncology (2023)

Cited0Views0Bibtex

Pembrolizumab (Pembro) or placebo (Pbo) plus chemotherapy (Chemo) for advanced HER2-negative gastric/gastroesophageal junction (G/GEJ) adenocarcinoma (KEYNOTE-859): Asia subgroup analysis

D-Y. Oh,Y. Bai,M. H. Ryu,J. Lee, J. Li,S. Luo,H. Pan,Y. Qu,J. Lu, L. Yang,H. Yasui,H. Yabusaki,C. J. Yen,W. W. L. Chan,K. Yamaguchi,K-H. Yeh,L. Yin,S. Bordia,P. Bhagia,S. Y. Rha

ANNALS OF ONCOLOGY (2023): S1526-S1526

Cited0Views0Bibtex

VP1-2023: Pembrolizumab (pembro) plus chemotherapy (chemo) as first-line therapy for advanced HER2-negative gastric or gastroesophageal junction (G/GEJ) cancer: Phase III KEYNOTE-859 study

S.Y. Rha,L.S. Wyrwicz, P.E.Y. Weber,Y. Bai,M.H. Ryu,J. Lee,F. Rivera,G.V. Alves,M. Garrido,K-K. Shiu,M. González Fernández, J. Li,M. Lowery,T. Cil,F.J.S.M. Cruz,S. Qin,L. Yin,S. Bordia,P. Bhagia,D-Y. Oh

Annals of Oncologyno. 3 (2023): 319-320

Cited22Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn